The 2023 Society for Vascular Surgery, American Venous Forum, and American Vein and Lymphatic Society clinical practice guidelines for the management of varicose veins of the lower extremities. Part II: Endorsed by the Society of Interventional Radiology and the Society for Vascular Medicine
- PMID: 37652254
- PMCID: PMC11523430
- DOI: 10.1016/j.jvsv.2023.08.011
The 2023 Society for Vascular Surgery, American Venous Forum, and American Vein and Lymphatic Society clinical practice guidelines for the management of varicose veins of the lower extremities. Part II: Endorsed by the Society of Interventional Radiology and the Society for Vascular Medicine
Erratum in
-
Correction.J Vasc Surg Venous Lymphat Disord. 2024 Sep;12(5):101923. doi: 10.1016/j.jvsv.2024.101923. J Vasc Surg Venous Lymphat Disord. 2024. PMID: 39160002 Free PMC article. No abstract available.
Abstract
The Society for Vascular Surgery, the American Venous Forum, and the American Vein and Lymphatic Society recently published Part I of the 2022 clinical practice guidelines on varicose veins. Recommendations were based on the latest scientific evidence researched following an independent systematic review and meta-analysis of five critical issues affecting the management of patients with lower extremity varicose veins, using the patients, interventions, comparators, and outcome system to answer critical questions. Part I discussed the role of duplex ultrasound scanning in the evaluation of varicose veins and treatment of superficial truncal reflux. Part II focuses on evidence supporting the prevention and management of varicose vein patients with compression, on treatment with drugs and nutritional supplements, on evaluation and treatment of varicose tributaries, on superficial venous aneurysms, and on the management of complications of varicose veins and their treatment. All guidelines were based on systematic reviews, and they were graded according to the level of evidence and the strength of recommendations, using the GRADE method. All ungraded Consensus Statements were supported by an extensive literature review and the unanimous agreement of an expert, multidisciplinary panel. Ungraded Good Practice Statements are recommendations that are supported only by indirect evidence. The topic, however, is usually noncontroversial and agreed upon by most stakeholders. The Implementation Remarks contain technical information that supports the implementation of specific recommendations. This comprehensive document includes a list of all recommendations (Parts I-II), ungraded consensus statements, implementation remarks, and best practice statements to aid practitioners with appropriate, up-to-date management of patients with lower extremity varicose veins.
Keywords: Ablation; Chronic venous disease; Compression; Cyanoacrylate; Endovascular; Endovenous; Foam; Guidelines; Laser; Mechanochemical; Radiofrequency; Saphenous vein; Sclerotherapy; Thrombophlebitis; Thrombosis; Varicose veins; Venoactive drugs; Venous insufficiency.
Copyright © 2023. Published by Elsevier Inc.
Conflict of interest statement
Disclosures J.F. is a paid speaker for Janssen Pharmaceuticals. M.L.G. has been paid a consulting fee by VitasupportMD and is on their advisory board. R.K. is a paid consultant for Abbott, Auxetics, Boston Scientific, Diachii Sankyo, Koya Medical, Medtronic, Penumbra, Philips, Surmodics, USA Therm, and VB Devices; is on DSMB/CEC for NAMSA and Prairie Education and Research Cooperative; and is on the Board of Trustees of The VIVA Foundation, the Society for Vascular Medicine, the American Vein and Lymphatic Society, and the Intersocietal Accreditation Council | Vascular Testing. A.T.O. is a primary investigator for preclinical research grants funded by Medtronic and SurModics. K.O. is an IAC executive board member, serves on the advisory board for Medtronic and Boston Scientific, is a speaker and ultrasound course host for Medtronic, is a speaker for Boston Scientific, a quality committee member of CDPHP, and PI for W. L. Gore & Associates, and for the Savve study for enVVeno Medical. S.W. is a paid speaker for Janssen Pharmaceuticals. P.G., P.F.L., M.H.M., M.M., J.A., K.B., R.L.B., M.D., M.S. E.F., A.H., A.J., S.V., and H.J.W. have no conflicts of interest.
References
-
- Rabe E., Guex J.J., Puskas A., Scuderi A., Fernandez Quesada F., Coordinators V.C.P. Epidemiology of chronic venous disorders in geographically diverse populations: results from the Vein Consult Program. Int Angiol. 2012;31:105–115. - PubMed
-
- Beebe-Dimmer J.L., Pfeifer J.R., Engle J.S., Schottenfeld D. The epidemiology of chronic venous insufficiency and varicose veins. Ann Epidemiol. 2005;15:175–184. - PubMed
-
- O'Donnell T.F., Jr., Passman M.A., Marston W.A., et al. Management of venous leg ulcers: clinical practice guidelines of the Society for Vascular Surgery (R) and the American Venous Forum. J Vasc Surg. 2014;60(2 Suppl):3S–59S. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical